Mark W. Zimmerman

1.9k total citations
24 papers, 706 citations indexed

About

Mark W. Zimmerman is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Mark W. Zimmerman has authored 24 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Neurology and 5 papers in Genetics. Recurrent topics in Mark W. Zimmerman's work include Neuroblastoma Research and Treatments (15 papers), Protein Degradation and Inhibitors (7 papers) and Signaling Pathways in Disease (4 papers). Mark W. Zimmerman is often cited by papers focused on Neuroblastoma Research and Treatments (15 papers), Protein Degradation and Inhibitors (7 papers) and Signaling Pathways in Disease (4 papers). Mark W. Zimmerman collaborates with scholars based in United States, United Kingdom and China. Mark W. Zimmerman's co-authors include A. Thomas Look, Adam D. Durbin, Brian J. Abraham, Shuning He, Richard A. Young, John S. Lazo, Gregg E. Homanics, Nina Weichert‐Leahey, Ting Tao and Hui Shi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Mark W. Zimmerman

22 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark W. Zimmerman United States 12 530 319 170 121 86 24 706
Katarina Ejeskär Sweden 16 400 0.8× 223 0.7× 188 1.1× 125 1.0× 39 0.5× 35 593
Marli E. Ebus Netherlands 12 452 0.9× 317 1.0× 162 1.0× 243 2.0× 71 0.8× 14 681
Susanne Fransson Sweden 15 359 0.7× 309 1.0× 183 1.1× 126 1.0× 40 0.5× 38 542
Jessica Theißen Germany 12 515 1.0× 441 1.4× 377 2.2× 153 1.3× 40 0.5× 15 754
Zaowen Chen United States 13 475 0.9× 396 1.2× 298 1.8× 312 2.6× 52 0.6× 15 745
Olesya Chayka United Kingdom 12 378 0.7× 159 0.5× 129 0.8× 210 1.7× 36 0.4× 17 571
Kai-Oliver Henrich Germany 9 361 0.7× 319 1.0× 208 1.2× 135 1.1× 40 0.5× 12 550
Jayanti Jagannathan United States 5 426 0.8× 374 1.2× 226 1.3× 153 1.3× 68 0.8× 6 605
Kristina Ruuth Sweden 13 392 0.7× 387 1.2× 170 1.0× 223 1.8× 32 0.4× 23 694
Wendy Fang United States 9 383 0.7× 86 0.3× 165 1.0× 100 0.8× 91 1.1× 17 563

Countries citing papers authored by Mark W. Zimmerman

Since Specialization
Citations

This map shows the geographic impact of Mark W. Zimmerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Zimmerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Zimmerman more than expected).

Fields of papers citing papers by Mark W. Zimmerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Zimmerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Zimmerman. The network helps show where Mark W. Zimmerman may publish in the future.

Co-authorship network of co-authors of Mark W. Zimmerman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Zimmerman. A scholar is included among the top collaborators of Mark W. Zimmerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Zimmerman. Mark W. Zimmerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prutsch, Nicole, Shuning He, Alla Berezovskaya, et al.. (2024). STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma. Cell Reports Medicine. 5(3). 101472–101472. 4 indexed citations
2.
Banerjee, Deblina, Hsien-Chao Chou, Man Xu, et al.. (2024). Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation. Nature Communications. 15(1). 3432–3432. 5 indexed citations
3.
Jing, Changbin, Nicole Prutsch, Shuning He, et al.. (2023). Synthetic lethal targeting of TET2‐mutant haematopoietic stem and progenitor cells by XPO1 inhibitors. British Journal of Haematology. 201(3). 489–501. 3 indexed citations
4.
Weichert‐Leahey, Nina, Hui Shi, Ting Tao, et al.. (2023). Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state. Journal of Clinical Investigation. 133(10). 8 indexed citations
5.
Oppel, Felix, Mark W. Zimmerman, Matthias Schürmann, et al.. (2022). p53 Pathway Inactivation Drives SMARCB1 -deficient p53 -wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition. Molecular Cancer Therapeutics. 21(11). 1689–1700. 4 indexed citations
6.
Zimmerman, Mark W., et al.. (2022). Intrinsic transcriptional heterogeneity in neuroblastoma guides mechanistic and therapeutic insights. Cell Reports Medicine. 3(5). 100632–100632. 10 indexed citations
7.
He, Shuning, Mark W. Zimmerman, Alla Berezovskaya, et al.. (2021). Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss. Oncogene. 40(38). 5718–5729. 4 indexed citations
8.
Zimmerman, Mark W., Nina Weichert‐Leahey, Belamy B. Cheung, et al.. (2021). MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation. Cancers. 13(19). 4783–4783. 9 indexed citations
9.
Wang, Lu, Tze King Tan, Adam D. Durbin, et al.. (2019). ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry. Nature Communications. 10(1). 5622–5622. 54 indexed citations
10.
Oppel, Felix, Ting Tao, Hui Shi, et al.. (2019). Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies. PLoS Genetics. 15(4). e1008039–e1008039. 36 indexed citations
11.
Durbin, Adam D., Mark W. Zimmerman, Neekesh V. Dharia, et al.. (2018). Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry. Nature Genetics. 50(9). 1240–1246. 145 indexed citations
12.
Zimmerman, Mark W., Yu Liu, Shuning He, et al.. (2018). c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification. PMC. 2 indexed citations
13.
Zimmerman, Mark W., Yu Liu, Shuning He, et al.. (2017). MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification. Cancer Discovery. 8(3). 320–335. 147 indexed citations
14.
Zimmerman, Mark W., Shuning He, Shizhen Zhu, et al.. (2017). Abstract 3871: Modeling the chromatin and transcriptional landscape of MYC and MYCN driven neuroblastoma in zebrafish. Cancer Research. 77(13_Supplement). 3871–3871. 1 indexed citations
15.
Zimmerman, Mark W., et al.. (2016). Studying the peripheral sympathetic nervous system and neuroblastoma in zebrafish. Methods in cell biology. 134. 97–138. 12 indexed citations
16.
Zimmerman, Mark W., Shuning He, Jimann Shin, et al.. (2016). Abstract 2433: Loss of chd5-mediated gene repression synergizes with MYCN to accelerate neuroblastoma tumorigenesis in zebrafish. Cancer Research. 76(14_Supplement). 2433–2433.
17.
Zimmerman, Mark W.. (2014). Opening the Door to Race-Based Real Estate Marketing: South-Suburban Housing Center v. Greater South Suburban Board of Realtors. ˜The œDe Paul law review. 41(4). 1271.
18.
Zimmerman, Mark W., Kelley E. McQueeney, Jeffrey S. Isenberg, et al.. (2014). Protein-tyrosine Phosphatase 4A3 (PTP4A3) Promotes Vascular Endothelial Growth Factor Signaling and Enables Endothelial Cell Motility. Journal of Biological Chemistry. 289(9). 5904–5913. 44 indexed citations
19.
Zimmerman, Mark W., et al.. (2014). Deletion of Ptp4a3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice. Stem Cell Research. 13(1). 164–171. 16 indexed citations
20.
Zimmerman, Mark W., Gregg E. Homanics, & John S. Lazo. (2013). Targeted Deletion of the Metastasis-Associated Phosphatase Ptp4a3 (PRL-3) Suppresses Murine Colon Cancer. PLoS ONE. 8(3). e58300–e58300. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarina Ejeskär Breakdown of academic impact, for papers by Marli E. Ebus Breakdown of academic impact, for papers by Susanne Fransson Breakdown of academic impact, for papers by Jessica Theißen Breakdown of academic impact, for papers by Zaowen Chen Breakdown of academic impact, for papers by Olesya Chayka Breakdown of academic impact, for papers by Kai-Oliver Henrich Breakdown of academic impact, for papers by Jayanti Jagannathan Breakdown of academic impact, for papers by Kristina Ruuth Breakdown of academic impact, for papers by Wendy Fang
Rankless by CCL
2026